
ATXI
Healthcare · Biotechnology · $922,590 market cap
$0.3888+0.08 (+27.4%)Nov 13, 1:30 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 13, 2025 | Time not confirmed | — | -0.21 | — |
| Aug 14, 2025 | Time not confirmed | — | 0.11 | — |
| May 13, 2025 | Before the open | -9.00 | -0.73 | +91.9% |
| Mar 31, 2025 | Time not confirmed | -0.09 | 3.83 | +4355.6% |
| Nov 14, 2024 | After the close | -0.94 | -1.92 | -104.3% |
| Aug 9, 2024 | After the close | -1.05 | -2.41 | -129.5% |
| May 15, 2024 | After the close | -9.00 | -15.40 | -71.1% |
| Mar 18, 2024 | After the close | -0.10 | 0.06 | +160.0% |
| Nov 13, 2023 | After the close | -19.50 | 4.50 | +123.1% |
| Aug 10, 2023 | After the close | -21.75 | -39.00 | -79.3% |
| May 12, 2023 | Before the open | -0.13 | -1.35 | -938.5% |
| Mar 30, 2023 | After the close | -56.25 | -98.93 | -75.9% |
| Nov 10, 2022 | After the close | -56.25 |
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioid to treat post-operative acute pain. The company was incorporated in 2015 and is headquartered in…
| -33.75 |
| +40.0% |
| Aug 15, 2022 | Before the open | -0.60 | -0.03 | +95.0% |
| May 16, 2022 | Before the open | -0.04 | -0.05 | -25.0% |
| Mar 25, 2022 | After the close | -0.04 | -0.05 | -25.0% |
| Nov 15, 2021 | Before the open | -56.25 | -56.25 | 0.0% |
| Aug 16, 2021 | After the close | -67.50 | -67.50 | 0.0% |
| May 17, 2021 | Before the open | -56.25 | -67.50 | -20.0% |
| Mar 31, 2021 | Before the open | -0.90 | -0.90 | 0.0% |
| Nov 4, 2020 | After the close | -112.50 | -67.50 | +40.0% |
| Aug 14, 2020 | Before the open | -118.13 | -123.75 | -4.8% |
| May 11, 2020 | Before the open | -196.88 | -90.00 | +54.3% |
| Mar 30, 2020 | Before the open | -4.28 | -4.95 | -15.7% |
| Nov 4, 2019 | Before the open | -360.00 | -157.50 | +56.3% |
| Aug 14, 2019 | Before the open | -382.50 | -483.75 | -26.5% |
| May 13, 2019 | Before the open | -483.75 | -922.50 | -90.7% |
| Mar 12, 2019 | Before the open | -7.00 | -5.55 | +20.7% |
| Nov 14, 2018 | After the close | -435.00 | -281.25 | +35.3% |
| Aug 14, 2018 | Before the open | -806.25 | -506.25 | +37.2% |
| May 3, 2018 | Before the open | -765.00 | -1158.75 | -51.5% |
| Mar 1, 2018 | After the close | — | -0.63 | — |